Literature DB >> 1932756

Hereditary elliptocytosis due to both qualitative and quantitative defects in membrane skeletal protein 4.1.

J G Conboy1, R Shitamoto, M Parra, R Winardi, A Kabra, J Smith, N Mohandas.   

Abstract

Protein 4.1 is an important structural component of the membrane skeleton that helps determine erythrocyte morphology and membrane mechanical properties. In a previous study we identified a case of human hereditary elliptocytosis (HE) in which decreased membrane mechanical stability was due to deletion of 80 amino acids encompassing the entire 10-Kd spectrin-actin binding domain. A portion of this domain (21 amino acids) is encoded by an alternatively spliced exon that is expressed in late but not early erythroid cells. We now report a case of canine HE in which the abnormal phenotype is caused by failure to express this alternative peptide in the mature red blood cell (RBC) membrane skeleton, in conjunction with quantitative deficiency of protein 4.1. Western blotting of RBC membranes from a dog with HE showed a truncated protein 4.1 that did not react with antibodies directed against the alternative peptide. In addition, sequencing of cloned reticulocyte protein 4.1 cDNA showed a precise deletion of 63 nucleotides comprising this exon. Normal dog reticulocytes did express this exon. Expression of this 21 amino acid peptide during erythroid maturation is therefore essential for proper assembly of a mechanically competent membrane skeleton, because RBCs lacking this peptide have unstable membranes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1932756

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  11 in total

1.  Decrease in hnRNP A/B expression during erythropoiesis mediates a pre-mRNA splicing switch.

Authors:  Victor C Hou; Robert Lersch; Sherry L Gee; Julie L Ponthier; Annie J Lo; Michael Wu; Chris W Turck; Mark Koury; Adrian R Krainer; Akila Mayeda; John G Conboy
Journal:  EMBO J       Date:  2002-11-15       Impact factor: 11.598

2.  Homozygous 4.1(-) hereditary elliptocytosis associated with a point mutation in the downstream initiation codon of protein 4.1 gene.

Authors:  N Dalla Venezia; F Gilsanz; N Alloisio; M T Ducluzeau; E J Benz; J Delaunay
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

3.  Protein 4.1N binding to nuclear mitotic apparatus protein in PC12 cells mediates the antiproliferative actions of nerve growth factor.

Authors:  K Ye; D A Compton; M M Lai; L D Walensky; S H Snyder
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

Review 4.  Role of tissue specific alternative pre-mRNA splicing in the differentiation of the erythrocyte membrane.

Authors:  E J Benz; S C Huang
Journal:  Trans Am Clin Climatol Assoc       Date:  1997

5.  Protein 4.1 deficiency associated with an altered binding to the spectrin-actin complex of the red cell membrane skeleton.

Authors:  F Lorenzo; N Dalla Venezia; L Morlé; F Baklouti; N Alloisio; M T Ducluzeau; L Roda; P Lefrançois; J Delaunay
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

6.  Erythrocytes carrying mutations in spectrin and protein 4.1 show differing sensitivities to invasion by Plasmodium falciparum.

Authors:  C A Facer
Journal:  Parasitol Res       Date:  1995       Impact factor: 2.289

7.  Transcriptional divergence and conservation of human and mouse erythropoiesis.

Authors:  Novalia Pishesha; Prathapan Thiru; Jiahai Shi; Jennifer C Eng; Vijay G Sankaran; Harvey F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-03       Impact factor: 11.205

8.  An isoform-specific mutation in the protein 4.1 gene results in hereditary elliptocytosis and complete deficiency of protein 4.1 in erythrocytes but not in nonerythroid cells.

Authors:  J G Conboy; J A Chasis; R Winardi; G Tchernia; Y W Kan; N Mohandas
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

9.  The 13-kD FK506 binding protein, FKBP13, interacts with a novel homologue of the erythrocyte membrane cytoskeletal protein 4.1.

Authors:  L D Walensky; P Gascard; M E Fields; S Blackshaw; J G Conboy; N Mohandas; S H Snyder
Journal:  J Cell Biol       Date:  1998-04-06       Impact factor: 10.539

10.  A dynamic alternative splicing program regulates gene expression during terminal erythropoiesis.

Authors:  Harold Pimentel; Marilyn Parra; Sherry Gee; Dana Ghanem; Xiuli An; Jie Li; Narla Mohandas; Lior Pachter; John G Conboy
Journal:  Nucleic Acids Res       Date:  2014-01-17       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.